|
3.1 Tabac
|
|
|
|
4.2 Dép., diag. & prono. - Génome
|
|
|
|
|
5.10 Traitements - Essais
|
|
|
|
5.12 Immunothérapies
|
|
|
|
5.2 Pharma
|
|
|
|
5.2.3 Pharma - économie
|
|
|
Supreme Court skeptical in case backed by drug makers [STAT]
|
|
|
|
|
|
The
generic companies and insurers allege that the industry exploits the
patent system to preserve monopolies on drugs, preventing generics from
entering the market and keeping prices high. The new reviews will help
bring drug costs down, they say.
|
|
|
|
|
|
|
5.3.4 Traitements - AMM (FDA, EMA)
|
|
|
|
5.4 Traitements - Economie
|
|
|
|
5.9 AACR
|
|
|
|
6. Lutte contre les cancers
|
|
|
Ovarian Cancers: Evolving Paradigms in Research and Care [The National Academies Press]
|
|
|
|
|
|
"Ovarian
Cancers" examines the state of the science in ovarian cancer research,
identifies key gaps in the evidence base and the challenges to
addressing those gaps, considers opportunities for advancing ovarian
cancer research, and examines avenues for translation and dissemination
of new findings and communication of new information to patients and
others.
|
|
|
|
|
|
|
6.1 Observation
|
|
|
|
6.6 Publications
|
|
|
You Pay to Read Research You Fund. That’s Ludicrous [WIRED]
|
|
|
|
|
|
We
need to change the model, not just tweak around the edges. An
alternative system, where all publicly-funded research is required to be
shared under a permissive license, would allow authors to unlock their
content and data for re-use with a global audience, and co-operate in
new discoveries and analysis.
|
|
|
|
|
|
|
6.8 Communication
|
|
|